JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | Feb 7 6:27 PM | Wolk Joseph J | Proposed Sale | 13,015 | $153.89 | $2.0M | — | View → |
| Dec 4, 2024 | Dec 4 6:25 PM | Hait William | Proposed Sale | 25,742 | $149.90 | $3.9M | — | View → |
| Aug 30, 2024 | Aug 30 7:51 PM | Decker Robert J | Proposed Sale | 5,635 | $165.06 | $930.1K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Grant/Award | 57,656 | $243.45 | 3,863(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 3,849 | — | 3,754(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Option Exercise | 39,242 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Grant/Award | 5,571 | $243.45 | 700(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Option Exercise | 683 | — | 687(D) | View → |
| Feb 13, 2026 | Feb 19 2:12 AM | Robert J DeckerVP Corporate Controller | Option Exercise | 3,053 | — | 0(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 51,648 | $157.92 | 59,854(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 3,196 | — | 3,692(D) | View → |
| Feb 15, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Grant/Award | 52,928 | $243.45 | 3,546(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Grant/Award | 29,020 | $243.45 | 1,944(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 2,024 | — | 2,126(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 14,357 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Grant/Award | 58,809 | $243.45 | 3,940(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Option Exercise | 3,441 | — | 3,692(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Option Exercise | 28,714 | — | 0(D) | View → |
| Feb 18, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 22,623 | $129.51 | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 2,054 | — | 2,051(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Grant/Award | 38,037 | $243.45 | 2,548(D) | View → |
| Feb 13, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 4,877 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 19 2:11 AM | Joaquin DuatoDirector, CEO and Chairman of the Board | Grant/Award | 141,193 | $243.45 | 9,459(D) | View → |